TATA Health (01255) Sets 31 March 2026 Board Meeting to Review FY 2025 Audited Results and Dividend Proposal

Bulletin Express

Mar 16

TATA Health International Holdings Limited (stock code: 01255) has scheduled a board meeting for Tuesday, 31 March 2026. The agenda includes:

• Reviewing and approving the audited financial statements for the year ended 31 December 2025.

• Considering the recommendation of a final dividend, if any.

• Addressing other routine corporate matters.

Board composition at the time of the announcement (16 March 2026) comprises one executive director (Zhang Ming Qi), two non-executive directors (Chu Chun Ho, Dominic; Chen Qi) and four independent non-executive directors (Huang Lin; Li Liang; Du Jianfeng; Tan Kaiguo).

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1169068049"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1169068049\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1169068049?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-16 21:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1169068049","market":"hk","top_or_hot":-1,"title":"TATA Health (01255) Sets 31 March 2026 Board Meeting to Review FY 2025 Audited Results and Dividend Proposal","media":"Bulletin Express","content":"<p>TATA Health International Holdings Limited (stock code: 01255) has scheduled a board meeting for Tuesday, 31 March 2026. The agenda includes:</p>\n<p>• Reviewing and approving the audited financial statements for the year ended 31 December 2025.</p>\n<p>• Considering the recommendation of a final dividend, if any.</p>\n<p>• Addressing other routine corporate matters.</p>\n<p>Board composition at the time of the announcement (16 March 2026) comprises one executive director (Zhang Ming Qi), two non-executive directors (Chu Chun Ho, Dominic; Chen Qi) and four independent non-executive directors (Huang Lin; Li Liang; Du Jianfeng; Tan Kaiguo).</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TATA Health (01255) Sets 31 March 2026 Board Meeting to Review FY 2025 Audited Results and Dividend Proposal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTATA Health (01255) Sets 31 March 2026 Board Meeting to Review FY 2025 Audited Results and Dividend Proposal\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-16 21:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TATA Health International Holdings Limited (stock code: 01255) has scheduled a board meeting for Tuesday, 31 March 2026. The agenda includes:</p>\n<p>• Reviewing and approving the audited financial statements for the year ended 31 December 2025.</p>\n<p>• Considering the recommendation of a final dividend, if any.</p>\n<p>• Addressing other routine corporate matters.</p>\n<p>Board composition at the time of the announcement (16 March 2026) comprises one executive director (Zhang Ming Qi), two non-executive directors (Chu Chun Ho, Dominic; Chen Qi) and four independent non-executive directors (Huang Lin; Li Liang; Du Jianfeng; Tan Kaiguo).</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01255","symbol_name":"TATA健康","start_time":0,"source_url":"","article_id":"1169068049","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1169068049","pubTimestamp":1773666158,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"TATA Health International Holdings Limited (stock code: 01255) has scheduled a board meeting for Tuesday, 31 March 2026. The agenda includes: • Reviewing and approving the audited financial...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01255":"TATA健康"},"translate_title":"塔塔健康(01255)定于2026年3月31日召开董事会会议，审查2025财年经审计业绩和股息提案","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01255":1},"content_text":"TATA Health International Holdings Limited (stock code: 01255) has scheduled a board meeting for Tuesday, 31 March 2026. The agenda includes:\n• Reviewing and approving the audited financial statements for the year ended 31 December 2025.\n• Considering the recommendation of a final dividend, if any.\n• Addressing other routine corporate matters.\nBoard composition at the time of the announcement (16 March 2026) comprises one executive director (Zhang Ming Qi), two non-executive directors (Chu Chun Ho, Dominic; Chen Qi) and four independent non-executive directors (Huang Lin; Li Liang; Du Jianfeng; Tan Kaiguo).","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}